Welcome to our dedicated page for Optinose SEC filings (Ticker: OPTN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Optinose's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Optinose's regulatory disclosures and financial reporting.
Schedule 13G/A filing by Nantahala Capital Management, LLC and two individuals reporting zero beneficial ownership in OptiNose, Inc. The filing states that as of June 30, 2025, Nantahala and its managing members, Wilmot B. Harkey and Daniel Mack, may be deemed beneficial owners of 0 shares of OptiNose common stock (CUSIP 68404V209), representing 0.00% of the class. The filing identifies Nantahala as an investment adviser organized in Massachusetts and lists the reporting persons' business address in New Canaan, Connecticut. Signatures include Nantahala through its Chief Compliance Officer and both individual reporting persons, dated August 14, 2025.
OptiNose, Inc. filing discloses that Rosalind Advisors, Rosalind Master Fund L.P., Steven Salamon and Gilad Aharon report beneficial ownership of 0 common shares (0.0%) of OptiNose common stock. The filing lists no sole or shared voting power and no sole or shared dispositive power for any reporting person.
The statement identifies Rosalind Advisors as an adviser and Salamon and Aharon as portfolio managers and includes a certification that the securities are held in the ordinary course of business and were not acquired to influence control; ownership is reported as 5% or less.